Powder: -20°C for 3 years
In solvent: -80°C for 2 years
Eslicarbazepine can be used for adjunctive therapy for adults with partial-onset seizures.
Description | Eslicarbazepine can be used for adjunctive therapy for adults with partial-onset seizures. |
In vitro | Eslicarbazepine is an anti-epileptic drug, chemically related to carbamazepine but with a more favorable safety profile. Eslicarbazepine acetate is a prodrug for eslicarbazepine (S-licarbazepine), which is a dual Inhibitor of β-Secretase and voltage-gated sodium channel[1][2]. |
Synonyms | Pazzul, Stedesa, Erelib, BIA 2-194, EC 810-248-9 |
Molecular Weight | 254.28 |
Formula | C15H14N2O2 |
CAS No. | 104746-04-5 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 12 mg/mL (47.19 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Eslicarbazepine 104746-04-5 Membrane transporter/Ion channel Neuroscience Beta-Secretase Sodium Channel Pazzul Stedesa Inhibitor Erelib BIA 2-194 inhibit EC 810-248-9 inhibitor